logo
Sign in

DELPHINUS MEDICAL TECHNOLOGIES, INC.

NOVI, MI · Founded 2010 · Medtech · Private

SoftVue, an automated breast ultrasound system with tissue-specific imaging capability for breast cancer screening and lesion characterization

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
NOVI, MI
Founded
2010
Latest Form D
$5.3M, Apr 2024
Total capital
$98.3M
Federal grants
$3.8M
5 awards · 2015–2018
Rank in peer group#242 of 538
Private capital raised
$94.5M
6 Form D · last Apr 2024
31 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
24
16 pending · first 2015
Rank in peer group#14 of 538

Capital timeline

20102012201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $98.3M$643K$985K$349K$963K$858K1st Form D$6M2nd Form D$39.5M3rd Form D$8.2M4th Form D$30.4M
2010201420182022FEDERAL ↑EQUITY ↓Cumulative $98.3M$985K$963K$858K2nd Form D$39.5M4th Form D$30.4M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$5.3M
  • Private capital raisedForm D · SEC · 5th filing$5M
  • Private capital raisedForm D · SEC · 4th filing$30.4M
  • Federal grantHealth and Human S · Phase II · Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.$858K
  • Private capital raisedForm D · SEC · 3rd filing$8.2M
  • Federal grantHealth and Human S · Phase II · Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.$963K
  • Federal grantHealth and Human S · Phase II · High-resolution, quantitative whole-breast ultrasound: bridging the gap to clinical practice$349K
  • Private capital raisedForm D · SEC · 2nd filing$39.5M
  • Private capital raisedForm D · SEC · 1st filing$6M
Show 2 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.$985K
  • Federal grantHealth and Human S · Phase II · High-resolution, quantitative whole-breast ultrasound: bridging the gap to clinical practice$643K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#242 · top 45%
  • Granted patents#14 · top 3%
  • Linked publications#12 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Chris J. SandersExecutive OfficerNamed in SEC Form D filings
  • Debra J. SaundersExecutive OfficerNamed in SEC Form D filings
  • Elise BermanExecutive OfficerNamed in SEC Form D filings
  • Francis DobschaExecutive OfficerNamed in SEC Form D filings
  • Heather RoneExecutive OfficerNamed in SEC Form D filings
  • Hugo BraunDirectorNamed in SEC Form D filings
Show all 22 people
  • John NeisDirectorNamed in SEC Form D filings
  • Mark J. ForchetteExecutive Officer, DirectorNamed in SEC Form D filings
  • Michael EmeryExecutive OfficerNamed in SEC Form D filings
  • Michael FultonDirectorNamed in SEC Form D filings
  • Michael GrossDirectorNamed in SEC Form D filings
  • Neb DuricExecutive OfficerNamed in SEC Form D filings
  • Neb J. Duric, Ph.D.Executive OfficerNamed in SEC Form D filings
  • Olivier RoyExecutive OfficerNamed in SEC Form D filings
  • Paul James McCreadieDirectorNamed in SEC Form D filings
  • Rachel BremDirectorNamed in SEC Form D filings
  • Robert P. KelchDirectorNamed in SEC Form D filings
  • Ronald HoDirectorNamed in SEC Form D filings
  • Scott WhiteExecutive Officer, DirectorNamed in SEC Form D filings
  • Shawn J. O'BrienExecutive OfficerNamed in SEC Form D filings
  • William C. GreenwayExecutive Officer, DirectorNamed in SEC Form D filings
  • W. James ProwseExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 24 granted of 40
Show all 40 patent records

Recent research by its founders

  • Assessing the feasibility of brain imaging with ultrasound tomography: in‑silico and in‑vitro evaluation20260 cites
  • Differentiable reverse‑time migration for sound speed estimation and aberration correction in medical pulse‑echo ultrasound20260 cites
  • Fast Fourier beamforming for arbitrary ultrasound imaging sequences based on a k‑space implementation of reverse‑time migration20260 cites

Related companies, and why

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .